Myelin Repair Foundation

Saratoga, CA United States

To accelerate the discovery of myelin repair treatments to improve the lives of people suffering from multiple sclerosis (MS), and to establish the Accelerated Research Collaboration™ (ARC™) model as a new paradigm for medical research. With its innovative model for medical research, its narrow focus, and its five-year timeline, the Myelin Repair Foundation is on track toward achieving its goal to license at least one myelin repair drug target by 2009. MRF’s Accelerated Research Collaboration model — bringing best-business practices to the world of academic research — is cutting the time to drug discovery in as much as one-half.